Cirqle Biomedical Contraception ApS: Financial statements 2020
CVR: 39865769
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Cirqle Biomedical Contraception ApS (CVR 39865769) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -4,132,723 and a net result of DKK -5,557,693. Equity in the 2020 report amounted to DKK 2,844,328. The solvency ratio was 26.4%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -4,132,723
- Profit/Loss
- DKK -5,557,693
- Equity
- DKK 2,844,328
- Total Assets
- DKK 10,782,694
- Employees
- 5
Official annual report
How creditworthy is Cirqle Biomedical Contraception ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 23, 2020, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Frederik Petursson Madsen has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Jesper Boysen has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Thomas Crouzier has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Frederik Petursson Madsen is registered as adm. dir. of Cirqle Biomedical Contraception ApS.
On September 17, 2020, the company changed its name from Cirqle Biomedical Contraception IVS to Cirqle Biomedical Contraception ApS.
As of September 16, 2020, Frederik Petursson Madsen has stepped down as director of Cirqle Biomedical Contraception ApS.
Cirqle Biomedical Contraception ApS has published its interim report for the period September 11, 2018 – December 31, 2019.
About Cirqle Biomedical Contraception ApS
Cirqle Biomedical Contraception ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cirqle Biomedical Contraception IVS and Circle Biomedical Contraception IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The board consists of Jesper Boysen (chair), Frederik Petursson Madsen and Thomas Crouzier. The company is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931.